Patients with anti-TPO IgE (during control or exacerbation periods) had a significantly higher frequency of atopy, total IgE levels, and asthma; patients without anti-TPO IgE (during the control and exacerbation periods) had a higher frequency of inducible urticaria. The gene discussed is IGHE; the disease is asthma.